Ausdal Financial Partners’s ACELYRIN SLRN Stock Holding History

Ausdal Financial Partners’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,800	Closed	-$31.6K	–	730
2025 Q1	$31.6K	Hold	12,800	–	–	﹤0.01%	640
2024 Q4	$40.2K	Sell	12,800 -6,500	-34%	-$31.5K	﹤0.01%	564
2024 Q3	$95.1K	Hold	19,300	–	–	0.01%	502
2024 Q2	$85.1K	Hold	19,300	–	–	0.01%	484
2024 Q1	$130K	Sell	19,300 -1,000	-5%	-$7.6K	0.02%	454
2023 Q4	$151K	Sell	20,300 -700	-3%	-$5.97K	0.02%	435
2023 Q3	$214K	Buy	+21,000	New	+$446K	0.03%	391

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ausdal Financial Partners's SLRN Position: Q2 2025 in Review

Ausdal Financial Partners sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 12,800 shares — an estimated $31.6K sold.

Ausdal Financial Partners first reported a position in SLRN in Q3 2023 and held it in 7 quarters. The position peaked at $214K in Q3 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Ausdal Financial Partners reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Ausdal Financial Partners sold 12,800 ACELYRIN shares in Q2 2025, an estimated $31.6K.
Ausdal Financial Partners first reported a position in ACELYRIN in Q3 2023 and held it in 7 quarters.
Ausdal Financial Partners's ACELYRIN position peaked at $214K in Q3 2023.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Ausdal Financial Partners's 13F filing for Q2 2025, filed 14 Aug 2025.